As interstitial fibrosis is a key driver of diabetic nephropathy progression, the Akita+/− Ren+/− mouse should provide new insights into disease pathogenesis, and also a means to test novel anti-fibrotic agents in the diabetic kidney. The gene discussed is REN; the disease is diabetic kidney disease.